Remalorelin was found, in a randomized double-blind, placebo-controlled study, to reduce the frequency and intensity of vomiting, and to accelerate gastric emptying in adult patients with diabetic Gastroparesis.
You can find the original article here on EndocinologyAdisor.com
You can see the published study results here in Gastrojournal.org
Relamorelin is under development by Rhythm Pharmaceuticals.
JIm Sliney Jr, Editor, ThePactBlog